NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹25 Cr | ₹61 Cr | ₹101 Cr | ₹135 Cr | ₹143 Cr |
What is the latest Total Non-Current Liabilities ratio of NATCO PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹25 Cr |
Mar2024 | ₹61 Cr |
Mar2023 | ₹101 Cr |
Mar2022 | ₹135 Cr |
Mar2021 | ₹143 Cr |
How is Total Non-Current Liabilities of NATCO PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹25 Cr | -59.18 | |
Mar2024 | ₹61 Cr | -39.30 | |
Mar2023 | ₹101 Cr | -25.61 | |
Mar2022 | ₹135 Cr | -5.46 | |
Mar2021 | ₹143 Cr | - |
Compare Total Non-Current Liabilities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,488.6 Cr | -1.2% | -11.3% | -44.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -1.2% |
-11.3% |
-44.1% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses